Pharmala Biotech Holdings Inc. (MDMA.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 08-2023 | 05-2023 | 02-2023 | 11-2022 | 08-2022 | |
| Sales | 439 | 0 | 93 | 0 | 8 |
| Cost of Goods | 78 | 0 | N/A | N/A | 0 |
| Gross Profit | 361 | 0 | N/A | N/A | 7 |
| Operating Expenses | 272 | 339 | 311 | 289 | 199 |
| Operating Income | 89 | -339 | -218 | -289 | -191 |
| Other Income | -169 | 0 | 146 | 0 | 0 |
| Pre-tax Income | -80 | -339 | -72 | -289 | -191 |
| Net Income Continuous | -80 | -339 | -72 | -289 | -191 |
| Net Income | $-80 | $-339 | $-72 | $-289 | $-191 |
| EBITDA(a) | $102 | $-326 | $-205 | $-275 | $-180 |